Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any
discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results
for the Year Ended March 31, 2024
(Based on Japanese GAAP)May 15, 2024
Company name:

DAIKEN MEDICAL CO., LTD.

Stock exchange listing: Tokyo
Stock code:
7775
Representative:
Inquiries:

URL

https://daiken-iki.co.jp

President
Chief of Headquarters BusinessKeiichi Yamada
Takuwa RyoAdministration Department
Scheduled date of ordinary general meeting of shareholders:

TEL0725-30-3150

June 20, 2024

Scheduled date to file Securities Report:
Scheduled date to commence dividend payments:

June 20, 2024
June 3, 2024

Preparation of supplementary material on financial results:
Holding of financial results meeting:

Yes
Yes

(for institutional investors and analysts)(Amounts less than one million yen are rounded down)
1. Non-consolidated financial results for the year ended March 31, 2024 (from April 1, 2023 to March 31, 2024)(1) Non-consolidated operating results

Percentages indicate year-on-year changes
Net salesYear ended March 31, 2024
Year ended March 31, 2023

Millions of yen
9,750
9,137

Operating profit
%
6.7
7.0

Millions of yen
1,442
1,054

Diluted earnings pershare
Yen
Yen
34.41
–
24.79
–

Earnings per share
Year ended March 31, 2024
Year ended March 31, 2023

Ordinary profit% Millions of yen
36.8
1,450(8.4)
1,053

Profit% Millions of yen
37.6
988(8.6)
712%
38.8(14.3)

Ordinary profit/total Operating profit/net
assetssales%%%
14.6
13.2
14.8
10.9
9.6
11.5

Profit/equity(2) Non-consolidated financial position
Total assets
As of March 31, 2024
As of March 31, 2023

Net assets

Equity ratio

Millions of yen
11,006
11,013

Millions of yen
7,022
6,597

Cash flows fromoperating activities
Millions of yen
1,555
989

Cash flows frominvesting activities
Millions of yen
(168)
(210)

Net assets per share%
63.5
59.7

Yen
243.32228.91(3) Non-consolidated cash flows

Year ended March 31, 2024
Year ended March 31, 2023

Cash flows from
Cash and cash equivalents
at end of periodfinancing activities
Millions of yen
Millions of yen(1,163)2,739(781)2,516

2. Cash dividends
Annual dividends per share
1st quarter-end 2nd quarter-end 3rd quarter-end Fiscal year-end

Year ended March 31, 2023
Year ended March 31, 2024
Year ending March 31, 2025
(Forecast)

Total cash
dividends (Total)

Total

Dividend payout
ratio (Nonconsolidated)

Ratio of dividends
to net assets (Nonconsolidated)

Yen

Yen

Yen

Yen

Yen

Millions of yen

%%

––

9.00
9.00

––

11.00
12.00

20.00
21.00

574
603

80.761.0

8.8
8.9–

9.00

–

13.00

22.00

1

61.4

3. Forecast of non-consolidated financial results for the year ending March 31, 2025 (from April 1, 2024 to March 31, 2025)
Percentages indicate year-on-year changes
Net sales
Millions of yen
Six months ending
September 30, 2024
Full year

Operating profit

Ordinary profit

Profit% Millions of yen% Millions of yen% Millions of yen

4,950

2.6

700(6.1)

700(6.7)

10,100

3.6

1,500

4.0

1,500

3.4

Earnings per share%Yen

480(10.7)

16.71

1,030

4.2

35.85

4. Notes(1) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations:
Changes in accounting policies due to other reasons:

NoNo

Changes in accounting estimates:
Restatement of prior period financial statements:

NoNo(2) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of March 31, 2024

31,840,000 shares As of March 31, 2023

31,840,000 shares

Number of treasury shares at the end of the period
As of March 31, 2024

3,111,563 shares As of March 31, 2023

3,111,561 shares

28,728,439 shares Year ended March 31, 2023

28,728,440 shares

Average number of shares during the period
Year ended March 31, 20242

Non-consolidated financial statements
Non-consolidated balance sheets(Thousands of yen)
As of March 31, 2023

As of March 31, 2024

AssetsCurrent assets
Cash and deposits
Notes receivable - trade

2,516,212
102,7632,739,141
68,087

Electronically recorded monetary claims - operating
Accounts receivable - trade

1,229,646
1,198,117

1,272,477
1,139,185

Finished goods
Work in process

1,004,266
88,420916,374
80,436

Raw materials
Prepaid expenses

422,011
18,958441,237
24,575

Other
Allowance for doubtful accounts

58,259(94)

49,516(93)

6,638,560

6,730,938

1,861,600
1,020

1,784,269
659

Machinery and equipment, net
Vehicles, net

163,717
1,882

192,773
1,310

Tools, furniture and fixtures, net
Land95,7801,703,670

119,211
1,703,670

23,394
219,171

14,431
170,210

4,070,238

3,986,537

Total current assets
Non-current assets
Property, plant and equipment
Buildings, netStructures, net

Leased assets, net
Construction in progress
Total property, plant and equipment
Intangible assets
Software

4,303

8,386

Telephone subscription right

5,103

5,103

Total intangible assets

9,406

13,489

10
1,871

10
7,070

Deferred tax assets
Guarantee deposits

230,596
52,323

205,587
52,287

Membership
Life insurance funds

13,1008,797

13,1008,797

Long-term accounts receivable - otherAllowance for doubtful accounts

13,150(24,650)

13,150(24,650)

Investments and other assets
Investments in capital
Long-term prepaid expenses

Total investments and other assets
Total non-current assets
Total assets

3

295,198

275,352

4,374,843

4,275,379

11,013,404

11,006,318

(Thousands of yen)
As of March 31, 2023

As of March 31, 2024

Liabilities
Current liabilities
Notes payable - trade

7,580

2,645

588,016
521,621

601,186
462,979

1,000,000
659,972

1,080,000
389,972

Accounts payable - other
Lease liabilities

141,902
9,875

313,219
8,238

Accrued expenses
Income taxes payable

70,312242,047

65,426
252,070

Accrued consumption taxes
Deposits received

44,405
11,697106,170
10,056

Notes payable - facilities
Electronically recorded obligations - facilities

20,29338,292

7,986
26,037

Electronically recorded obligations - operating
Accounts payable - trade
Short-term borrowings
Current portion of long-term borrowings

Other

13,448

13,941

3,369,464

3,339,930

1,013,395
16,266

623,423
8,028

Long-term guarantee deposits
Other

14,624
2,507

9,955
2,507

Total non-current liabilities

1,046,792

643,914

4,416,257

3,983,844

Total current liabilities
Non-current liabilities
Long-term borrowings
Lease liabilities

Total liabilities
Net assets
Shareholders' equity
Share capital

495,875

495,875

Capital surplus
Legal capital surplus

400,875

400,875

Total capital surplus

400,875

400,875

Retained earnings
Legal retained earnings

23,75023,750

Other retained earnings
General reserve
Retained earnings brought forward
Total retained earnings

690,000

690,000

6,792,339

7,206,373

7,506,089

7,920,123

Treasury shares(1,826,583)(1,826,584)

Total shareholders' equity

6,576,256

6,990,288

20,89032,185

6,597,146

7,022,474

11,013,404

11,006,318

Share acquisition rights
Total net assets
Total liabilities and net assets

4Non-consolidated statements of income(Thousands of yen)

Net sales
Cost of sales

Fiscal year ended

Fiscal year ended

March 31, 2023

March 31, 2024

9,137,102

9,750,166

973,067
5,532,957

1,004,266
5,530,879

157,585
8,000

193,548
9,833

Total

6,671,610

6,738,527

Transfer to other accountEnding finished goods inventory

60,402
1,004,266

53,971
916,374

Total cost of sales

5,606,941

5,768,181

Gross profit

3,530,161

3,981,984

Selling, general and administrative expenses

2,475,701

2,539,343

Operating profit

1,054,459

1,442,640

Beginning finished goods inventory
Cost of products manufactured
Cost of purchased goods
Cost of construction by the outside order

Non-operating income
Interest income

00Commission income
Compensation income

357672

1,036
3,965

Foreign exchange gains
Gain on forfeiture of unclaimed dividends

464471

2,908628

Gain on sale of scraps
Miscellaneous income–
1,2222,355
1,289

Total non-operating income

3,190

12,185

3,965

4,825

480

Non-operating expenses
Interest expenses
Other
Total non-operating expenses

4,013

4,825

1,053,635

1,450,000

Loss on retirement of non-current assets
Loss on cancellation of leases

28,609
–

5,505
8,035

Total extraordinary losses

28,60913,5401,025,025

1,436,459

383,109422,848

Ordinary profit
Extraordinary losses

Profit before income taxes
Income taxes - current
Income taxes - deferred(70,146)

25,008

Total income taxes

312,962

447,857

Profit712,062

988,6025

Non-consolidated statements of changes in equity
Fiscal year ended March 31, 2023
(Thousands of yen)
Shareholders' equity
Capital surplus

Retained earnings
Other retained earnings

Share capital

Balance at beginning of period

495,875

Legal capitalsurplus

Total capitalsurplus

Legal retained
earnings

400,875

400,875

23,750Retainedearnings
brought
forwardGeneralreserve
690,000

Total retained
earnings

6,654,845

7,368,595

Dividends of surplus(574,568)(574,568)

Profit712,062712,062

Changes during period

Purchase of treasury shares
Net changes in items other thanshareholders' equity
Total changes during period
Balance at end of period–––––

137,494

137,494495,875

400,875

400,875

23,750690,000

6,792,339

7,506,089

ShareacquisitionrightsTotal net assets

7,368

6,446,131

Shareholders' equity
Total
shareholders'equityTreasurysharesBalance at beginning of period(1,826,582)

6,438,763

Changes during period
Dividends of surplus
ProfitPurchase of treasury shares(0)(574,568)(574,568)

712,062712,062(0)(0)

Net changes in items other thanshareholders' equity
Total changes during period
Balance at end of period

13,521

13,521(0)

137,493

13,521

151,015(1,826,583)

6,576,256

20,8906,597,146

6

Fiscal year ended March 31, 2024
(Thousands of yen)
Shareholders' equity
Capital surplus

Retained earnings
Other retained earnings

Share capital

Balance at beginning of period

495,875

Legal capitalsurplus

Total capitalsurplus

Legal retained
earnings

400,875

400,875

23,750Retainedearnings
brought
forwardGeneralreserve
690,000

Total retainedearnings

6,792,339

7,506,089Dividends of surplus(574,568)(574,568)

Profit988,602

988,602

Changes during period

Purchase of treasury shares
Net changes in items other thanshareholders' equity
Total changes during period
Balance at end of period–––––

414,033

414,033

495,875

400,875

400,875

23,750690,000

7,206,373

7,920,123

ShareacquisitionrightsTotal net assets

20,8906,597,146

Shareholders' equity
Total
shareholders'equityTreasurysharesBalance at beginning of period(1,826,583)

6,576,256

Changes during period
Dividends of surplus(574,568)(574,568)

Profit988,602

988,602(1)(1)

Purchase of treasury shares(1)

Net changes in items other thanshareholders' equity
Total changes during period
Balance at end of period

11,295

11,295(1)

414,032

11,295425,327(1,826,584)

6,990,288

32,185

7,022,474

7Non-consolidated statements of cash flows(Thousands of yen)
Fiscal year ended

Fiscal year ended

March 31, 2023

March 31, 2024

Cash flows from operating activities
Profit before income taxes

1,025,025

1,436,459

Depreciation
Share-based payment expenses

267,295
13,521

214,276
11,295

3(0)

(1)
(0)

Interest expenses
Decrease (increase) in trade receivables

3,965(99,151)

4,825
50,777

Decrease (increase) in inventories
Increase (decrease) in trade payables

29,839113,308

76,649(50,405)

Loss on retirement of non-current assets
Loss on cancellation of leases

28,609
–

5,505
8,035

Decrease (increase) in accounts receivable - other
Increase (decrease) in accounts payable - other(9,714)240(1,786)
175,627(586)(4,889)(31,776)

61,765

Increase (decrease) in allowance for doubtful accounts
Interest and dividend income

Increase (decrease) in accrued expenses
Increase/decrease in consumption taxes payable/consumption
taxes refund receivable
Other, net
SubtotalInterest and dividends received
Interest paid

31,81010,907

1,372,392

1,999,041

0(3,762)0(4,903)

Income taxes paid

(379,472)(438,637)

Net cash provided by (used in) operating activities

989,156

1,555,500

Purchase of property, plant and equipment
Purchase of intangible assets(197,949)(1,100)(161,900)(6,903)

Payments of guarantee deposits
Proceeds from refund of guarantee deposits(12,065)
588

(338)
374

Net cash provided by (used in) investing activities(210,526)(168,767)

Cash flows from investing activities

Cash flows from financing activities
Net increase (decrease) in short-term borrowings–

80,000

Proceeds from long-term borrowings
Repayments of long-term borrowings

400,000(604,492)–(659,972)

Purchase of treasury shares
Dividends paid

(0)(565,320)(1)(573,955)

Repayments of lease liabilities(11,194)(9,875)

Net cash provided by (used in) financing activities(781,007)(1,163,804)

Net increase (decrease) in cash and cash equivalents(2,377)

222,929

Cash and cash equivalents at beginning of period

2,518,589

2,516,212

Cash and cash equivalents at end of period

2,516,212

2,739,1418